Prevalence and risk factors of long COVID among maintenance hemodialysis patients post SARS‐CoV‐2 infection: A one‐year follow‐up study in China

Abstract Patients undergoing maintenance hemodialysis (MHD) are a high‐risk group susceptible to SARS‐CoV‐2 infection and long‐COVID syndrome appearance. However, there is limited and unclear evidence for long COVID in MHD patients. We collected the general information, symptoms, signs and laboratory indices of 366 MHD patients infected with COVID‐19 and conducted 12 months follow‐up with a series of questionnaires. As a result, 285 MHD patients had long COVID, with the most common symptoms were fatigue (84.69%) and muscle weakness (72.45%). Mobility problem ( p < 0.001), anxiety/depression ( p = 0.002) and breathlessness ( p < 0.001) were more prevalent in long COVID patients than in non‐long COVID patients. Persistent long COVID people were more likely to report all domains problems of the EQ‐5D‐5L. Age, female, inadequate dialysis (Kt/V < 1.2), coagulation abnormalities (d‐dimer > 1 mg/L) and more comorbidities were risk factors for the development of long COVID. In addition to these factors, elevated inflammatory markers (CRP > 10 mg/L) represent an extra risk factor for the persistence of long COVID symptoms in MHD patients. And more than 80% of long COVID symptoms would resolve after 1 year in MHD patients, of which the sixth month after COVID‐19 infection is a critical turning point. In conclusion, more than 68% of MHD patients have long COVID, which has a poor impact on their health status and quality of life. These risk factors for the development and persistence of long COVID deserve the attention of clinicians.